Skip to content

Treatment of Atrial Fibrillation in the Community Settings

Treatment of Atrial Fibrillation in the Community Settings

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06151132
Enrollment
430
Registered
2023-11-30
Start date
2016-01-01
Completion date
2023-03-01
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Arrhythmia, Cardiovascular Diseases

Brief summary

Description of treatment of cardiovascular diseases in community settings in Russia

Detailed description

The study will describe different treatment modalities used in management of cardiovascular diseases in community hospital in small town of Tarusa in Russia. This part of the study will focus on atrial fibrillation and its treatment.

Interventions

Direct current cardioversion to maintain sinus rhythm during rhythm control strategy

Sponsors

ITMO University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patients undergoing direct current cardioversion for atrial fibrillation or flutter

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Restoration of sinus rhythm1 dayRestoration of sinus rhythm during direct current cardioversion
Maintenance in rhythm control strategy7 yearsMaintenance in rhythm control strategy during treatment of atrial fibrillation

Other

MeasureTime frameDescription
Body mass indexDuring procedureweight in kilograms divided by the square of height in meters
Heart FailureBefore procedurePast history of chronic heart failure
Arterial hypertensionBefore procedurePast history of arterial hypertension
Coronary heart diseaseBefore procedurePast history of coronary heart disease
Diabetes mellitusBefore procedurePast history of diabetes mellitus
Type of arrhythmiaDuring procedureAtrial fibrillation or atrial flutter
GenderDuring procedureGender
SettingsDuring procedureWhether procedure performed in inpatient or outpatient settings
TEEBefore procedureWhether transesophageal echocardiography was performed before procedure
First procedureBefore procedureWhether it is the first cardioversion in the patient
Echo LVEFDuring procedureLeft ventricular ejection fraction measured by echocardiography
Echo LAVIDuring procedureLeft atrium volume index measured by echocardiography
Duration of arrhythmiaBefore procedureDuration of episode of arrhythmia before cardioversion
AgeDuring procedureAge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026